SCA
PHAS
Snowden Capital Advisors’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-60,800
| Closed | -$10K | – | 1182 |
|
|
2022
Q3 | $10K | Hold |
60,800
| – | – | ﹤0.01% | 1106 |
|
|
2022
Q2 | $36K | Buy |
60,800
+9,000
| +17% | +$5.33K | ﹤0.01% | 1102 |
|
|
2022
Q1 | $68K | Buy |
51,800
+23,000
| +80% | +$30.2K | ﹤0.01% | 1007 |
|
|
2021
Q4 | $75K | Buy |
28,800
+7,800
| +37% | +$20.3K | ﹤0.01% | 926 |
|
|
2021
Q3 | $65.3K | Buy |
21,000
+1,000
| +5% | +$3.11K | ﹤0.01% | 862 |
|
|
2021
Q2 | $74.4K | Hold |
20,000
| – | – | ﹤0.01% | 867 |
|
|
2021
Q1 | $69.2K | Buy |
+20,000
| New | +$69.2K | ﹤0.01% | 790 |
|